Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-3.14%
↑ 96% above average
Average (27q)
-82.20%
Historical baseline
Range
High:90.44%
Low:-1650.83%
Volatility
-2118.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -3.14% |
| Q2 2025 | -23.54% |
| Q1 2025 | 59.47% |
| Q4 2024 | -201.28% |
| Q3 2024 | -2.38% |
| Q2 2024 | -5.40% |
| Q1 2024 | 9.96% |
| Q4 2023 | -14.84% |
| Q3 2023 | -46.88% |
| Q2 2023 | 23.37% |
| Q1 2023 | 23.85% |
| Q4 2022 | -20.33% |
| Q3 2022 | -210.83% |
| Q2 2022 | 62.12% |
| Q1 2022 | 16.57% |
| Q4 2021 | -173.51% |
| Q3 2021 | -15.12% |
| Q2 2021 | -25.58% |
| Q1 2021 | 48.13% |
| Q4 2020 | -348.11% |
| Q3 2020 | -22.07% |
| Q2 2020 | 13.98% |
| Q1 2020 | 27.31% |
| Q4 2019 | -0.16% |
| Q3 2019 | 87.10% |
| Q2 2019 | -1650.83% |
| Q1 2019 | 90.44% |
| Q4 2018 | 0.00% |